Latest TriVascular Inc. Stories
500-patient, real-world study of innovative, lowest profile EVAR system bolsters strong library of clinical evidence. Santa Rosa, CA (PRWEB) January 27, 2014
Proceeds to Support Commercialization, Product Development and Clinical Research Efforts Santa Rosa, CA (PRWEB) November 18, 2013 TriVascular, Inc.
Outcomes demonstrate excellent safety and effectiveness in the treatment of patients with Abdominal Aortic Aneurysms (AAA). Santa Rosa, CA (PRWEB) August 27,
Over 2000 patients have been treated with innovative 14 French Endovascular Aortic Repair (EVAR) device. Santa Rosa, CA (PRWEB) July 17, 2013 TriVascular,
SANTA ROSA, Calif., July 25, 2011 /PRNewswire/ -- TriVascular, Inc. today announced the successful treatment of the first 5 patients in the OVATION study, a multicenter, prospective, European Post Market Registry. The patients were treated in Germany at Stadtisches Klinikum, Karlsruhe by Prof.